Skip Nav Destination
About the Journal
Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms.. Read More About the Journal
Impact Factor
6.009
Featured Articles
Trending - Altmetric
AZD4625 is a potent and selective inhibitor of KRAS G12C
Last mentioned on Thursday August 18 2022
Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand–Addicted Pancreatic Cancer
Last mentioned on Tuesday July 19 2022
CDK7 inhibition synergizes with topoisomerase I inhibition in small cell lung cancer cells by inducing ubiquitin-mediated proteolysis of RNA polymerase II
Last mentioned on Tuesday July 19 2022
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors
Last mentioned on Thursday August 18 2022
Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells
Last mentioned on Tuesday August 16 2022